What are you looking for?
Demographic, socioeconomic, and clinical factors were associated with both the likelihood of receiving low-dose atropine and the rate of myopia progression amongst pediatric patients in a retrospective analysis. The data presented at AAO 2026, found that Asian race, male sex, younger age, and lower neighborhood deprivation were associated with greater odds of treatment, and treatment... ...
Theialife said the U.S. Food and Drug Administration has aligned with key elements of the planned Phase 3 development program for ND10,...
Children treated with high-dose atropine combined with dual-focus soft contact lenses (DFCLs) showed minimal axial elongation, with no significant difference compared with...
By Monica Jong, BOptom, PhD, FAAO, FBCLA The contents of this article are informational only and are not intended to be a...
Demographic, socioeconomic, and clinical factors were associated with both the likelihood of receiving low-dose atropine and the rate of myopia progression amongst pediatric patients in a retrospective analysis. The data...
Theialife said the U.S. Food and Drug Administration has aligned with key elements of the planned Phase 3 development program for ND10, an investigational oral extended-release therapy for progressive pediatric...
Children treated with high-dose atropine combined with dual-focus soft contact lenses (DFCLs) showed minimal axial elongation, with no significant difference compared with high-dose atropine plus photochromatic multifocal spectacles (PMS), according...
By Monica Jong, BOptom, PhD, FAAO, FBCLA The contents of this article are informational only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment...
A 35-item scale assessing parents’ knowledge, attitudes, and practices (KAP) related to myopia prevention and control demonstrated good reliability and validity in a survey of parents of children and adolescents....
Atropine eye drops at concentrations of 0.01% to 0.05% slowed pediatric myopia progression over 2 years and were not associated with clinically meaningful rebound after treatment cessation, according to a...
Defocus Incorporated Multiple Segments (DIMS) spectacle lenses were noninferior to orthokeratology lenses (OKL) for slowing axial elongation in myopic children after 18 months of treatment, according to a study. The...
Young adults who previously wore defocus incorporated multiple segments (DIMS) spectacle lenses reported high long-term satisfaction and confidence in their effectiveness for slowing myopia progression, but the cost of the...
Children with advanced myopia treated with nightly 0.01% atropine experienced slower myopia progression over 12 months than during untreated periods in a randomized crossover pilot trial. The 24-month open-label study...
Repeated low-level red-light (RLRL) therapy produced greater changes in 3D macular morphology than 0.01% low-dose atropine over 12 months in children with myopia, according to a study. The secondary analysis...
Monitoring axial length (AL) progression before treatment may help predict the effectiveness of optical myopia control interventions, according to a study. Researchers evaluated 128 eyes from 64 pediatric patients who...
Children with myopia who switched to a different type of myopia-control spectacle experienced a temporary slowing of myopia progression, according to a study. The retrospective matched-cohort study 1,012 children and...
Thirty minutes of tablet use in children with myopia reduced tear film stability and worsened some symptoms of eye strain, according to a study, which also found a higher screen...
